Publisher Correction: The janus-kinase inhibitor ruxolitinib in SARS-CoV-2 induced acute respiratory distress syndrome (ARDS).
Neubauer A, Johow J, Mack E, Burchert A, Meyn D, Kadlubiec A, Torje I, Wulf H, Vogelmeier CF, Hoyer J, Skevaki C, Muellenbach RM, Keller C, Schade-Brittinger C, Rolfes C, Wiesmann T.
Neubauer A, et al. Among authors: wiesmann t.
Leukemia. 2021 Oct;35(10):3038. doi: 10.1038/s41375-021-01412-0.
Leukemia. 2021.
PMID: 34518646
Free PMC article.
No abstract available.